On March 3,2020,the National Health Commission and the National Administration of Traditional Chinese Medicine of China jointly promulgated the Notice on Printing and Distributing the Diagnosis and Treatment Protocol ...On March 3,2020,the National Health Commission and the National Administration of Traditional Chinese Medicine of China jointly promulgated the Notice on Printing and Distributing the Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia(Trial Version 7).The content has been revised and supplemented on the basis of the Version 6,including etiological characteristics and pathological changes in lung,heart,kidney,spleen,liver,gallbladder,esophagus,stomach and intestinal mucosal epithelium.In particular,the diagnosis and treatment methods of traditional Chinese medicine are supplemented.It provides an evidence-based diagnosis and treatment protocol for the treatment and recovery of suspected and confirmed cases of novel coronavirus pneumonia with traditional Chinese medicine and Western medicine.展开更多
Novel coronavirus infection not only damages lung function,but also causes myocardial injury,elevated myocardial enzymes and heart failure,especially for patients with basic heart diseases who develop COVID-19,the fir...Novel coronavirus infection not only damages lung function,but also causes myocardial injury,elevated myocardial enzymes and heart failure,especially for patients with basic heart diseases who develop COVID-19,the first consideration should be the protection of cardiac function.Based on the theory of intermingled phlegm,blood stasis and toxin of heart disease put forward by Master Lei Zhongyi,the dialectical treatment thinking of COVID-19 patients from the concept of damage of phlegm,blood stasis and toxin to the heart were discussed.During the diagnosis,critical stage and recovery period of COVID-19,expectorant and blood-activating agents,heat and detoxification agents can be added to promote lung and asthma,free Bizheng and remove blood stasis,calm the heart and calm the mind,and promote the recovery of cardiopulmonary functions.展开更多
With the wide spread of COVID-19,some studies have confirmed that novel coronavirus enters the cell through the binding of spike protein and ACE2 protein,which has the risk of causing the virus to enter the cell to ac...With the wide spread of COVID-19,some studies have confirmed that novel coronavirus enters the cell through the binding of spike protein and ACE2 protein,which has the risk of causing the virus to enter the cell to accelerate its transmission.ACEI and ARB are the key drugs for the treatment of hypertension and are widely used in clinic.They are good for ventricular and vascular remodeling in patients with hypertension,coronary heart disease and heart failure.ACEI and ARB drugs may increase the expression of ACE2 in lung tissue and increase the risk of aggravation of the disease.According to the advice of hypertension experts:for mild ordinary COVID-19 patients with hypertension,we can consider discontinuing ACEI and ARB drugs,while for severe COVID-19 patients with hypertension,ACEI and ARB drugs should be stopped immediately.During the discontinuation period,temporary replacement therapy with diuretics,dipine and vasodilatation hypotensive drugs can be considered.展开更多
Flexible strain sensors have become a key component of intelligent wearable electronics.However,the fabrication of strain sensors with wide workable strain ranges and high sensitivity remains a great challenge.Additio...Flexible strain sensors have become a key component of intelligent wearable electronics.However,the fabrication of strain sensors with wide workable strain ranges and high sensitivity remains a great challenge.Additionally,the rapid development of polymer composites based strain sensors has produced a large amount of e-waste.Therefore,the development of strain sensors with wide strain sensing ranges and high sensitivity based on degradable materials is necessary.In this work,a silicone blocked polyurethane(Si-BPU)with high stretchability and degradability was synthesized and composited with carbon nanotubes(CNTs)to fabricate fibrous strain sensors.The synthesized 0.5%Si-BPU exhibited good biodegradability with a weight loss of 16.47%in 42 days.The Si-BPU/12CNTs fiber based strain sensor achieved a sensing range of 0%–353.3%strain,gauge factor(GF)of 206.3 at 250%strain and of 4,513.2 at 353.3%strain,reliable stability under 10,000 repeated stretching–releasing cycles.Moreover,the Si-BPU/12CNTs strain sensor showed rapid response time(<163 ms)and was capable of monitoring various human body movements(elbow bending,finger bending,breath,swallow).In consequence,this work provides a new and effective strategy for the development of sustainable wearable electronic devices.展开更多
基金The 3rd Session of National TCM Master/National Famous TCM Doctor Inheritance Studio Construction Project of National Administration of Traditional Chinese Medicine[Guo Zhong Yi Yao Ban Ren Jiao Han(2018)119].
文摘On March 3,2020,the National Health Commission and the National Administration of Traditional Chinese Medicine of China jointly promulgated the Notice on Printing and Distributing the Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia(Trial Version 7).The content has been revised and supplemented on the basis of the Version 6,including etiological characteristics and pathological changes in lung,heart,kidney,spleen,liver,gallbladder,esophagus,stomach and intestinal mucosal epithelium.In particular,the diagnosis and treatment methods of traditional Chinese medicine are supplemented.It provides an evidence-based diagnosis and treatment protocol for the treatment and recovery of suspected and confirmed cases of novel coronavirus pneumonia with traditional Chinese medicine and Western medicine.
基金the Project of the Third National Master of Traditional Chinese Medicine of National Administration of Traditional Chinese Medicine/National Famous Traditional Chinese Medicine Inheritance Studio Construction(No.119(2018)of Education Letter of the State Office of Traditional Chinese Medicine).
文摘Novel coronavirus infection not only damages lung function,but also causes myocardial injury,elevated myocardial enzymes and heart failure,especially for patients with basic heart diseases who develop COVID-19,the first consideration should be the protection of cardiac function.Based on the theory of intermingled phlegm,blood stasis and toxin of heart disease put forward by Master Lei Zhongyi,the dialectical treatment thinking of COVID-19 patients from the concept of damage of phlegm,blood stasis and toxin to the heart were discussed.During the diagnosis,critical stage and recovery period of COVID-19,expectorant and blood-activating agents,heat and detoxification agents can be added to promote lung and asthma,free Bizheng and remove blood stasis,calm the heart and calm the mind,and promote the recovery of cardiopulmonary functions.
基金The Third Session of National TCM Master Project of the National Administration of Traditional Chinese Medicine/National Famous TCM Doctor Inheritance Studio Construction Project(GuoZhong YiYaoBanRenJiaoHan2018119)。
文摘With the wide spread of COVID-19,some studies have confirmed that novel coronavirus enters the cell through the binding of spike protein and ACE2 protein,which has the risk of causing the virus to enter the cell to accelerate its transmission.ACEI and ARB are the key drugs for the treatment of hypertension and are widely used in clinic.They are good for ventricular and vascular remodeling in patients with hypertension,coronary heart disease and heart failure.ACEI and ARB drugs may increase the expression of ACE2 in lung tissue and increase the risk of aggravation of the disease.According to the advice of hypertension experts:for mild ordinary COVID-19 patients with hypertension,we can consider discontinuing ACEI and ARB drugs,while for severe COVID-19 patients with hypertension,ACEI and ARB drugs should be stopped immediately.During the discontinuation period,temporary replacement therapy with diuretics,dipine and vasodilatation hypotensive drugs can be considered.
基金the National Natural Science Foundation of China(Nos.51703108 and 52003130)the Postdoctoral Science Foundation of China(No.2019M652318)Taishan Scholar Foundation of Shandong,China(No.tsqn201909100)for financial support.
文摘Flexible strain sensors have become a key component of intelligent wearable electronics.However,the fabrication of strain sensors with wide workable strain ranges and high sensitivity remains a great challenge.Additionally,the rapid development of polymer composites based strain sensors has produced a large amount of e-waste.Therefore,the development of strain sensors with wide strain sensing ranges and high sensitivity based on degradable materials is necessary.In this work,a silicone blocked polyurethane(Si-BPU)with high stretchability and degradability was synthesized and composited with carbon nanotubes(CNTs)to fabricate fibrous strain sensors.The synthesized 0.5%Si-BPU exhibited good biodegradability with a weight loss of 16.47%in 42 days.The Si-BPU/12CNTs fiber based strain sensor achieved a sensing range of 0%–353.3%strain,gauge factor(GF)of 206.3 at 250%strain and of 4,513.2 at 353.3%strain,reliable stability under 10,000 repeated stretching–releasing cycles.Moreover,the Si-BPU/12CNTs strain sensor showed rapid response time(<163 ms)and was capable of monitoring various human body movements(elbow bending,finger bending,breath,swallow).In consequence,this work provides a new and effective strategy for the development of sustainable wearable electronic devices.
